AdipoRon is a synthetic small molecule that acts as an adiponectin receptor agonist, developed for the potential treatment of metabolic disorders including type 2 diabetes, obesity, cardiovascular disease,… Read more
AdipoRon is a synthetic small molecule that acts as an adiponectin receptor agonist, developed for the potential treatment of metabolic disorders including type 2 diabetes, obesity, cardiovascular disease, and non-alcoholic fatty liver disease. This category features a comprehensive range of reference standards, including the AdipoRon API, along with its pharmacopeial and non-pharmacopeial impurities and relevant metabolites. These materials are essential for rigorous analytical testing, method validation, and quality control during pharmaceutical development and impurity profiling. Additionally, stable isotope-labelled versions of this compound are available to facilitate precise pharmacokinetic studies and metabolic profiling investigations. By utilizing these high-quality reference materials, laboratories can ensure the accuracy and reliability of their analytical data throughout the entire drug development lifecycle of AdipoRon.